Jane Street’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.45M | Sell |
39,100
-10,000
| -20% | -$303K | ﹤0.01% | 5756 |
|
|
2026
Q1 | $1.66M | Sell |
49,100
-127,500
| -72% | -$3.61M | ﹤0.01% | 5439 |
|
|
2025
Q4 | $4.81M | Buy |
176,600
+118,600
| +204% | +$4.16M | ﹤0.01% | 3283 |
|
|
2025
Q3 | $2.33M | Buy |
+58,000
| New | +$2.18M | ﹤0.01% | 4659 |
|
|
2024
Q4 | – | Sell |
-8,300
| Closed | -$369K | – | 9294 |
|
|
2024
Q3 | $369K | Sell |
8,300
-17,400
| -68% | -$790K | ﹤0.01% | 7702 |
|
|
2024
Q2 | $1.11M | Buy |
25,700
+2,200
| +9% | +$79.4K | ﹤0.01% | 5571 |
|
|
2024
Q1 | $687K | Buy |
+23,500
| New | +$629K | ﹤0.01% | 6114 |
|
|
2023
Q3 | – | Sell |
-11,200
| Closed | -$317K | – | 8541 |
|
|
2023
Q2 | $317K | Sell |
11,200
-25,900
| -70% | -$645K | ﹤0.01% | 7037 |
|
|
2023
Q1 | $852K | Sell |
37,100
-54,000
| -59% | -$1.43M | ﹤0.01% | 5321 |
|
|
2022
Q4 | $2.56M | Buy |
91,100
+35,700
| +64% | +$1.01M | ﹤0.01% | 3469 |
|
|
2022
Q3 | $1.57M | Sell |
55,400
-13,700
| -20% | -$367K | ﹤0.01% | 4607 |
|
|
2022
Q2 | $1.53M | Buy |
69,100
+45,300
| +190% | +$1.02M | ﹤0.01% | 4662 |
|
|
2022
Q1 | $693K | Sell |
23,800
-96,900
| -80% | -$2.96M | ﹤0.01% | 6863 |
|
|
2021
Q4 | $3.97M | Buy |
120,700
+11,200
| +10% | +$451K | ﹤0.01% | 3209 |
|
|
2021
Q3 | $5.05M | Buy |
109,500
+13,600
| +14% | +$657K | ﹤0.01% | 2712 |
|
|
2021
Q2 | $5.29M | Buy |
95,900
+24,700
| +35% | +$1.38M | ﹤0.01% | 2546 |
|
|
2021
Q1 | $3.68M | Sell |
71,200
-36,300
| -34% | -$1.8M | ﹤0.01% | 2882 |
|
|
2020
Q4 | $4.66M | Buy |
107,500
+40,100
| +59% | +$1.59M | ﹤0.01% | 2226 |
|
|
2020
Q3 | $2.36M | Sell |
67,400
-65,900
| -49% | -$2.89M | ﹤0.01% | 2787 |
|
|
2020
Q2 | $7.13M | Buy |
133,300
+124,100
| +1,349% | +$5.75M | 0.01% | 1462 |
|
|
2020
Q1 | $326K | Sell |
9,200
-15,900
| -63% | -$735K | ﹤0.01% | 4111 |
|
|
2019
Q4 | $1.2M | Buy |
+25,100
| New | +$949K | ﹤0.01% | 2535 |
|
|
2018
Q4 | – | Sell |
-3,600
| Closed | -$278K | – | 4855 |
|
|
2018
Q3 | $278K | Sell |
3,600
-3,200
| -47% | -$257K | ﹤0.01% | 4308 |
|
|
2018
Q2 | $573K | Buy |
+6,800
| New | +$593K | ﹤0.01% | 3444 |
|
|
2017
Q3 | – | Sell |
-4,500
| Closed | -$232K | – | 4380 |
|
|
2017
Q2 | $232K | Buy |
+4,500
| New | +$230K | ﹤0.01% | 3879 |
|
|
2016
Q4 | – | Sell |
-18,200
| Closed | -$961K | – | 3974 |
|
|
2016
Q3 | $961K | Buy |
+18,200
| New | +$793K | ﹤0.01% | 2027 |
|
Other funds holding AGIO
FCM
LCM
AC
EAM
NAMI
Jane Street's AGIO Position: Q2 2026 in Review
Jane Street reduced its Agios Pharmaceuticals (AGIO) stake by 28% in Q2 2026, selling an estimated $5.84M and leaving 492,598 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2231.
Jane Street first reported a position in AGIO in Q3 2013 and has held it in 35 quarters since. The position peaked at $30.5M in Q4 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.
- Jane Street held 492,598 shares of Agios Pharmaceuticals worth $18.3M as of Q2 2026.
- Jane Street sold 192,642 Agios Pharmaceuticals shares in Q2 2026, an estimated $5.84M.
- Agios Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2231 holding.
- Jane Street first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 35 quarters since.
- Jane Street's Agios Pharmaceuticals position peaked at $30.5M in Q4 2025.
- 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.